Top Story

Marketing authorization application filed in Europe for Durasert 3-year uveitis treatment

June 22, 2017

A marketing authorization application has been filed to the European Medicines Agency for the approval to market Durasert 3-year treatment for posterior segment uveitis, according to a pSivida press release.

The treatment has seen its primary efficacy endpoints met in two phase 3 trials, reducing the recurrence of posterior segment uveitis in patients through 6 months.

NovaBay reports $4 million quarterly loss

June 22, 2017
NovaBay Pharmaceuticals announced a $4 million net loss in the first quarter of 2017 compared with a net loss of $5.1 million in the same quarter of last year. Research…

AMA supports efforts to improve substance abuse disorder coverage

June 21, 2017
Experts from four leading nonprofits in the addiction field have determined that existing legislation does not adequately protect insurance coverage of substance abuse…
FDA News

FDA commissioner calls for public input on lifting generic barriers

June 21, 2017
In introducing the FDA’s Drug Competition Action Plan, the commissioner announced his intent to assess ways FDA rules may be misused to create obstacles against…

CMS proposes rule to increase flexibility, reduce burdens

June 21, 2017
CMS recently issued a proposed rule to update the Quality Payment Program as required by the Medicare Access and CHIP Reauthorization Act of 2015 to simplify reporting…
More News Headlines »
Clinical Science

The Quantitative Measurements of Vascular Density and Flow Areas of Macula Using Optical Coherence Tomography Angiography in Normal Volunteers

Ophthalmic Surgery, Lasers and Imaging Retina, June 2017, Volume 48 Issue 6
The quantification of the density of macular vascular networks and blood flow areas in the foveal and parafoveal area…
More »

Treating Advanced Dry Age-related Macular Degeneration and Geographic Atrophy: Here and Now

This activity is supported by an educational grant from Genentech, Inc.

Age-related macular degeneration (AMD) is a deterioration or breakdown of the eye's macula. At present, pharmacotherapy…
More »
Meeting News

VIDEO: Some patients with diabetes at high risk for edema after cataract surgery

June 13, 2017
More »